M

Min Wang

University of Electronic Science and Technology of China

ORCID: 0009-0003-7063-1553

Publishes on Mesenchymal stem cell research, Mitochondrial Function and Pathology, Cancer-related molecular mechanisms research. 53 papers and 558 citations.

53Publications
558Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Aging Atlas: a multi-omics database for aging biology
Guang‐Hui Liu, Yīmíng Bào, Jing Qu et al.|Nucleic Acids Research|2020
Cited by 336Open Access

Organismal aging is driven by interconnected molecular changes encompassing internal and extracellular factors. Combinational analysis of high-throughput 'multi-omics' datasets (gathering information from genomics, epigenomics, transcriptomics, proteomics, metabolomics and pharmacogenomics), at either populational or single-cell levels, can provide a multi-dimensional, integrated profile of the heterogeneous aging process with unprecedented throughput and detail. These new strategies allow for the exploration of the molecular profile and regulatory status of gene expression during aging, and in turn, facilitate the development of new aging interventions. With a continually growing volume of valuable aging-related data, it is necessary to establish an open and integrated database to support a wide spectrum of aging research. The Aging Atlas database aims to provide a wide range of life science researchers with valuable resources that allow access to a large-scale of gene expression and regulation datasets created by various high-throughput omics technologies. The current implementation includes five modules: transcriptomics (RNA-seq), single-cell transcriptomics (scRNA-seq), epigenomics (ChIP-seq), proteomics (protein-protein interaction), and pharmacogenomics (geroprotective compounds). Aging Atlas provides user-friendly functionalities to explore age-related changes in gene expression, as well as raw data download services. Aging Atlas is freely available at https://bigd.big.ac.cn/aging/index.

Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke
Wenbo Zhao, Sijie Li, Chuanhui Li et al.|JAMA Neurology|2024
Cited by 54Open Access

Importance: Evidence supports using antiplatelet therapy in patients with acute ischemic stroke. However, neurological deterioration remains common under the currently recommended antiplatelet regimen, leading to poor clinical outcomes. Objective: To determine whether intravenous tirofiban administered within 24 hours of stroke onset prevents early neurological deterioration in patients with acute noncardioembolic stroke compared with oral aspirin. Design, Setting, and Participants: This investigator-initiated, multicenter, open-label, randomized clinical trial with blinded end-point assessment was conducted at 10 comprehensive stroke centers in China between September 2020 and March 2023. Eligible patients were aged 18 to 80 years with acute noncardioembolic stroke within 24 hours of onset and had a National Institutes of Health Stroke Scale (NIHSS) score of 4 to 20. Intervention: Patients were assigned randomly (1:1) to receive intravenous tirofiban or oral aspirin for 72 hours using a central, web-based, computer-generated randomization schedule; all patients then received oral aspirin. Main Outcome: The primary efficacy outcome was early neurological deterioration (increase in NIHSS score ≥4 points) within 72 hours after randomization. The primary safety outcome was symptomatic intracerebral hemorrhage within 72 hours after randomization. Results: A total of 425 patients were included in the intravenous tirofiban (n = 213) or oral aspirin (n = 212) groups. Median (IQR) age was 64.0 years (56.0-71.0); 124 patients (29.2%) were female, and 301 (70.8%) were male. Early neurological deterioration occurred in 9 patients (4.2%) in the tirofiban group and 28 patients (13.2%) in the aspirin group (adjusted relative risk, 0.32; 95% CI, 0.16-0.65; P = .002). No patients in the tirofiban group experienced intracerebral hemorrhage. At 90-day follow-up, 3 patients (1.3%) in the tirofiban group and 3 (1.5%) in the aspirin group died (adjusted RR, 1.15; 95% CI, 0.27-8.54; P = .63), and the median (IQR) modified Rankin scale scores were 1.0 (0-1.25) and 1.0 (0-2), respectively (adjusted odds ratio, 1.28; 95% CI, 0.90-1.83; P = .17). Conclusions and Relevance: In patients with noncardioembolic stroke who were seen within 24 hours of symptom onset, tirofiban decreased the risk of early neurological deterioration but did not increase the risk of symptomatic intracerebral hemorrhage or systematic bleeding. Trial Registration: ClinicalTrials.gov Identifier: NCT04491695.

Calculating Probabilistic Carbon Emission Flow: An Adaptive Regression-Based Framework
Mingchen Ma, Yaowang Li, Ershun Du et al.|IEEE Transactions on Sustainable Energy|2024
Cited by 21

Carbon intensities are beginning to be used as incentives for consumer-driven carbon reduction. Guided by time-varying carbon intensities, consumers can schedule loads in priority order to use more electricity during low-carbon periods. However, carbon intensities cannot be perfectly forecasted in advance due to the fluctuation of loads and renewable energy. The probabilistic distribution of carbon intensities can be calculated by the grid operator and used as a reference for power consumers. This paper presents a probabilistic carbon emission flow model to calculate the distribution of carbon intensities for consumers. An adaptive regression-based calculation framework combined with a carbon pattern dictionary technique is proposed to handle the high calculation complexity caused by the nonlinearity of the carbon emission flow model. The simulation results from the case studies demonstrate the accuracy and efficiency of our proposed approach.

Hierarchical Ultrafiltration-Catalysis Ceramic Membrane for Enhanced Oily Wastewater Treatment: The Synergy Effect between High-Efficiency Catalysis and Separation
Caihong Liu, Xihui Jiang, Zhiqiang Sun et al.|ACS ES&T Engineering|2024
Cited by 17

Catalytic membranes that enable simultaneous micropollutant degradation during oil/water separation have emerged as a promising candidate for treating complex emulsified oily wastewater. However, this hybrid system suffers from membrane fouling and subsequent radical quenching. Herein, we overcome these challenges by developing a novel hierarchical filtration-catalysis ceramic membrane to achieve efficient gradient decontamination. This membrane comprises a top hydrophilic MWCNT layer deposited on a CuFe2O4-immobilized ceramic membrane to construct CCuFeCM. A pristine ceramic membrane (CM) and a CuFe2O4-immobilized membrane (CuFeCM) served as controls. Our results demonstrated that CCuFeCM presents the most alleviated fouling potential (∼18% of flux decline) and TOC removal (91%) when treating synthetic textile wastewater containing a mineral oil-in-water emulsion with RhB. Besides that, CCuFeCM achieves the highest PMS-based RhB degradation capability (100%) and initial reaction rate (0.684 min–1). Quenching experiments and EPR analyses show that SO4–•, •OH, and 1O2 are responsible for the CCuFeCM/PMS oxidation system, and 1O2 is the dominant reactive species. The synergistic effect of oil separation and catalytic decomposition is mainly ascribed to the ordered arrangement of selective separation in advance to avoid interference with subsequent AOPs, which allows for micropollutants that are transmitted into internal membrane channels for confined catalytic oxidation. Furthermore, replication filtration tests indicate that CCuFeCM shows durable stable degradation and antifouling performance after simple cleaning. The specific functionality of oil isolation, catalyst anchor, and mass transfer effect reaction compartmentation provides a novel strategy for efficient gradient removal of multiple pollutants in water, which highlights promising application potential under realistic conditions.